Endomatic

Endovascular Left Atrial Appendage Closure Device

Health Tech & Life Sciences
Active
Seed Or Yehuda, Israel Founded 2018
Last updated 2026-06-18
Total raised
$1.0M
Last: 2025-08
Stage
Seed
Founded
2018
Headcount
3
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences

About

Endomatic develops a break through endovascular Left Atrial Appendage (“LAA”) closure device to prevent stroke.

Since a clot formation in the LAA is the primary cause for stroke in Atrial Fibralation patients, the interventional cardiologists and electrophysiologists routinely perform procedures which occlude the LAA with an implantable device.

As the implant come in contact with the heart’s flowing blood it may lead to device related thrombus (DRT), which is the clinicians highest concern, since it means that such procedures actively induce the stroke risk.

Endomatic patented technology expects to eliminate the risk of DRT due to its non-thrombogenic nature.

The company is endorsed with the top clinicians, including a world leader practitioner who became the head of its SAB and an investor.

Funding history · 4 rounds · $1.0M total

2025-08
Undisclosed
2024-09
Undisclosed
2024-03
Undisclosed
2023-01

Q&A

What is Endomatic's primary focus?
Endomatic develops an endovascular Left Atrial Appendage (LAA) closure device designed to prevent stroke, particularly in Atrial Fibrillation patients.
What is the key innovation of Endomatic's technology?
Endomatic's patented technology aims to eliminate the risk of device-related thrombus (DRT), a common concern with existing LAA closure implants, due to its non-thrombogenic nature.
When was Endomatic founded?
Endomatic was founded in June 2018.
Where is Endomatic headquartered?
Endomatic is headquartered in Or Yehuda, Israel.
What is Endomatic's total funding raised to date?
Endomatic has raised a total of $1,000,000 USD.
Which investor participated in Endomatic's January 2023 funding round?
Peregrine Ventures participated in Endomatic's funding round in January 2023.
What is the current product stage of Endomatic's device?
Endomatic's product is currently in the R&D stage.
Does Endomatic hold any patents?
Yes, Endomatic holds one patent.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cardiologycardiovascularmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2018-6
Employees (exact)3

Radar intelligence

Patents

EPO2